You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
The Emerging Federalism of U.S. Biotechnology Policy
David J. Webber
Politics and the Life Sciences
Vol. 14, No. 1 (Feb., 1995), pp. 65-72
Published by: Association for Politics and the Life Sciences
Stable URL: http://www.jstor.org/stable/4236099
Page Count: 8
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Biotechnology is an evolving policy issue involving a wide variety of federal and state policymakers. While most public and scholarly attention has been focused at the national level, a good deal of state policymaking activity regarding biotechnology has already taken place. The biotechnology issue is not a single, well-defined policy issue but rather a cluster of related issues and concerns. This analysis identifies eight facets of the biotechnology policy issue that have surfaced during congressional debate, committee hearings, and public discussions. This eight-fold characterization of biotechnology development is used to describe recent congressional and state legislative activity affecting biotechnology. Both the complexity and multifaceted nature of the biotechnology issue, and the manner with which it has been dealt by federal and state policymakers, have contributed to the dynamic nature of federalism surrounding this issue.
Politics and the Life Sciences © 1995 Association for Politics and the Life Sciences